This is a Validated Antibody Database (VAD) review about human CD24, based on 142 published articles (read how Labome selects the articles), using CD24 antibody in all methods. It is aimed to help Labome visitors find the most suited CD24 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD24 synonym: CD24A

Invitrogen
mouse monoclonal (SN3)
  • flow cytometry; human; fig s3
Invitrogen CD24 antibody (Thermo Fisher, MA5-11828) was used in flow cytometry on human samples (fig s3). BMC Cancer (2022) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 1c
Invitrogen CD24 antibody (eBioscience, 11-0247-42) was used in flow cytometry on human samples (fig 1c). Theranostics (2021) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; fig 2c
Invitrogen CD24 antibody (Thermo Fisher Scientific, 17-0247-42) was used in flow cytometry on human samples (fig 2c). Stem Cell Reports (2019) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; fig 1
Invitrogen CD24 antibody (eBioscience, eBioSN3) was used in flow cytometry on human samples (fig 1). Cancers (Basel) (2019) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; 1:50; fig 3a, 3b
Invitrogen CD24 antibody (eBioscience/Thermo, 17-0247-42) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 3e, s4b
Invitrogen CD24 antibody (EBioscience, 17-0247-41) was used in flow cytometry on human samples (fig 3e, s4b). Breast Cancer Res (2019) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 2g
Invitrogen CD24 antibody (Thermo Fisher, 14-0247-82) was used in flow cytometry on human samples (fig 2g). Cell Rep (2019) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 1s1
In order to investigate DNA repair in CD44+/CD24- cells, Invitrogen CD24 antibody (eBioscience, 48-0247-42) was used in flow cytometry on human samples (fig 1s1). elife (2017) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 7c
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, Invitrogen CD24 antibody (eBioscience, 12-0247-42) was used in flow cytometry on human samples (fig 7c). Front Immunol (2016) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • immunohistochemistry; human; fig 1
Invitrogen CD24 antibody (eBioscience, 17-0247) was used in immunohistochemistry on human samples (fig 1). Oncogene (2017) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen CD24 antibody (Invitrogen, SN3) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 2c
In order to propose that loss of Llgl1 results in epidermal growth factor receptor mislocalization and leads to pre-neoplastic changes, Invitrogen CD24 antibody (eBioscience, 11-0247) was used in flow cytometry on human samples (fig 2c). Oncotarget (2016) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD24 antibody (Invitrogen, SN3) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human; fig 3
In order to learn about the reduction of an in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells after tunicamycin-induced endoplasmic reticulum stress, Invitrogen CD24 antibody (Thermo Scientific, MA1-10154) was used in flow cytometry on human samples (fig 3). Exp Toxicol Pathol (2016) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • immunocytochemistry; human; 1:50; fig 6
Invitrogen CD24 antibody (eBioscience, 17-0247-42) was used in immunocytochemistry on human samples at 1:50 (fig 6). BMC Biol (2016) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; 1:50; loading ...; fig 7f
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen CD24 antibody (eBioscience, 25-0247-41) was used in flow cytometry on human samples at 1:50 (fig 7f). Nat Cell Biol (2016) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; loading ...; fig 2a
In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, Invitrogen CD24 antibody (eBioscience, A5-2H10) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human
In order to assess the role of B cells in tolerant kidney transplant recipients, Invitrogen CD24 antibody (Invitrogen, SN3) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human
In order to discuss the features of paroxysmal nocturnal hemoglobinuria, Invitrogen CD24 antibody (eBioscience, eBioSN3) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human
Invitrogen CD24 antibody (eBioscience, eBioSN3) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human; tbl 2
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CD24 antibody (eBioscience, SN3) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human
Invitrogen CD24 antibody (eBioscience, 12-0247- 42) was used in flow cytometry on human samples . Oncogene (2015) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human; tbl 2
In order to determine the phenotype and function of stem/progenitor cells in normal mammary epithelial cell populations and their malignant counterparts, Invitrogen CD24 antibody (Invitrogen, SN3) was used in flow cytometry on human samples (tbl 2). BMC Cancer (2013) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human
In order to use flow cytometry to detect malignant cells in body cavity fluids, Invitrogen CD24 antibody (Caltag Lab, Invitrogen, MHCD2422) was used in flow cytometry on human samples . Cytometry A (2010) ncbi
mouse monoclonal (eBioSN3 (SN3 A5-2H10))
  • flow cytometry; human
In order to identify markers of human fetal kidney stem cells, Invitrogen CD24 antibody (eBioscience, 12-0247) was used in flow cytometry on human samples . PLoS ONE (2009) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human
In order to discuss the frequency and contribution of CD27- memory B cells to systemic lupus erythematosus, Invitrogen CD24 antibody (Caltag Laboratories, SN3) was used in flow cytometry on human samples . J Immunol (2007) ncbi
mouse monoclonal (SN3)
  • flow cytometry; human
In order to evaluate the use of flow cytometry to identify the Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma, Invitrogen CD24 antibody (Caltag, SN3) was used in flow cytometry on human samples . Am J Clin Pathol (2006) ncbi
BioLegend
mouse monoclonal (ML5)
  • flow cytometry; human; fig s4a
BioLegend CD24 antibody (BioLegend, 311104) was used in flow cytometry on human samples (fig s4a). J Clin Endocrinol Metab (2022) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:100; loading ...
BioLegend CD24 antibody (BioLegend, 311116) was used in flow cytometry on human samples at 1:100. Immunity (2021) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:100; loading ...
BioLegend CD24 antibody (BioLegend, ML5) was used in flow cytometry on human samples at 1:100. Nature (2021) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:20; loading ...; fig 2d
BioLegend CD24 antibody (Biolegend, ML5) was used in flow cytometry on human samples at 1:20 (fig 2d). elife (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD24 antibody (BioLegend, 311135) was used in flow cytometry on human samples (fig 2e). Cell (2018) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD24 antibody (Biolegend, ML5) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD24 antibody (Biolegend, 311102) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 4d
BioLegend CD24 antibody (Biolegend, 311120) was used in flow cytometry on human samples (fig 4d). J Clin Invest (2018) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 2b
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BioLegend CD24 antibody (BioLegend, 311118) was used in flow cytometry on human samples (fig 2b). Oncogenesis (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:50; loading ...; fig s8c
In order to investigate how LACTB suppresses breast cancer cell growth, BioLegend CD24 antibody (BioLegend, 311118) was used in flow cytometry on human samples at 1:50 (fig s8c). Nature (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig s10m
BioLegend CD24 antibody (Biolegend, ML5) was used in flow cytometry on human samples (fig s10m). Nature (2016) ncbi
mouse monoclonal (ML5)
BioLegend CD24 antibody (Biolegend, 311102) was used . Sci Rep (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; baboons; fig 5
In order to analyze how chimeric 2C10R4 anti-CD40 antibody therapy is essential for long-term survival of pig-to-primate cardiac xenograft (GTKO.hCD46.hTBM), BioLegend CD24 antibody (BioLegend, 311120) was used in flow cytometry on baboons samples (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 2,4
BioLegend CD24 antibody (Biolegend, #311120) was used in flow cytometry on human samples (fig 2,4). Proteomics (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 6
BioLegend CD24 antibody (Biolegend, ML5) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 3
BioLegend CD24 antibody (BioLegend, ML5) was used in flow cytometry on human samples (fig 3). J Surg Res (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend CD24 antibody (BioLegend, ML5) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR3006(N))
  • western blot; human; loading ...; fig 4b
Abcam CD24 antibody (Abcam, ab179821) was used in western blot on human samples (fig 4b). Thorac Cancer (2022) ncbi
domestic rabbit monoclonal (EPR3006(N))
  • western blot; human; loading ...; fig 4a
Abcam CD24 antibody (abcam, ab179821) was used in western blot on human samples (fig 4a). Cell Death Discov (2020) ncbi
mouse monoclonal (SN3)
  • immunocytochemistry; human; fig 1
Abcam CD24 antibody (Abcam, ab30350) was used in immunocytochemistry on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (SN3)
  • other; human; 1:100; fig 5a
Abcam CD24 antibody (Abcam, ab30350) was used in other on human samples at 1:100 (fig 5a). Cancer Cell Int (2015) ncbi
Miltenyi Biotec
human monoclonal (REA832)
  • flow cytometry; human; loading ...; fig s3f
Miltenyi Biotec CD24 antibody (Miltenyi, 130-112-849) was used in flow cytometry on human samples (fig s3f). Cell (2019) ncbi
human monoclonal (REA832)
  • immunohistochemistry - frozen section; human; loading ...; fig 3e
Miltenyi Biotec CD24 antibody (Miltenyi Biotec, 130-112-846) was used in immunohistochemistry - frozen section on human samples (fig 3e). Cell (2019) ncbi
mouse monoclonal (32D12)
  • flow cytometry; human; loading ...; fig 1f
Miltenyi Biotec CD24 antibody (Miltenyi Biotec, 32D12) was used in flow cytometry on human samples (fig 1f). J Autoimmun (2018) ncbi
mouse monoclonal (32D12)
  • flow cytometry; human; loading ...; fig 2b
Miltenyi Biotec CD24 antibody (Miltenyi Biotec, 32D12) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
mouse monoclonal (32D12)
  • flow cytometry; human; 1:100; fig 1
  • immunohistochemistry; human; fig 5
Miltenyi Biotec CD24 antibody (Miltenyi Biotec, 130-095-954) was used in flow cytometry on human samples at 1:100 (fig 1) and in immunohistochemistry on human samples (fig 5). Mol Med Rep (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (SN3)
  • flow cytometry; human; 1:100; loading ...; fig 3a
Santa Cruz Biotechnology CD24 antibody (Santa Cruz, sc-19585) was used in flow cytometry on human samples at 1:100 (fig 3a). Cancers (Basel) (2020) ncbi
mouse monoclonal (ML5)
  • western blot; human; fig 5
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Santa Cruz Biotechnology CD24 antibody (Santa Cruz, SC-53660) was used in western blot on human samples (fig 5). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (ML5)
  • western blot; mouse; 1:1000; fig 2c
  • western blot; human; 1:1000; fig 3b
Santa Cruz Biotechnology CD24 antibody (Santa Cruz, sc-53660) was used in western blot on mouse samples at 1:1000 (fig 2c) and in western blot on human samples at 1:1000 (fig 3b). Nat Commun (2015) ncbi
Bio-Rad
mouse monoclonal (SN3)
  • immunocytochemistry; human; loading ...; fig s1a
Bio-Rad CD24 antibody (Serotec, MCA1379) was used in immunocytochemistry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (SN3)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Bio-Rad CD24 antibody (SEROTEC, SN3) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
Beckman Coulter
mouse monoclonal (ALB9)
  • flow cytometry; human; loading ...; fig 5a
Beckman Coulter CD24 antibody (Beckman Coulter, IM2645) was used in flow cytometry on human samples (fig 5a). BMC Cancer (2019) ncbi
mouse monoclonal (ALB9)
  • flow cytometry; human; loading ...; fig 2a
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, Beckman Coulter CD24 antibody (Beckman Coulter, ALB9) was used in flow cytometry on human samples (fig 2a). Clin Immunol (2017) ncbi
mouse monoclonal (ALB9)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter CD24 antibody (Beckman Coulter (Immunotech), ALB9) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (ALB9)
  • other; human; 200 ug/ml; fig 1
Beckman Coulter CD24 antibody (Beckman Coulter, IM0118) was used in other on human samples at 200 ug/ml (fig 1). J Extracell Vesicles (2016) ncbi
mouse monoclonal (ALB9)
  • flow cytometry; human
Beckman Coulter CD24 antibody (Beckman-Coulter, ALB9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
BD Biosciences
mouse monoclonal (ML5)
  • flow cytometry; rat; loading ...; fig 9
BD Biosciences CD24 antibody (BD Horizon, ML5) was used in flow cytometry on rat samples (fig 9). PLoS ONE (2022) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:20; fig 5e
BD Biosciences CD24 antibody (BD Bioscience, 562405) was used in flow cytometry on human samples at 1:20 (fig 5e). Nat Commun (2022) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD24 antibody (BD Pharmingen, 561646) was used in flow cytometry on human samples (fig 3a). JBMR Plus (2022) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:20; fig 3b
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples at 1:20 (fig 3b). Neoplasia (2022) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 7d
BD Biosciences CD24 antibody (BD Pharmingen, 555427) was used in flow cytometry on human samples (fig 7d). Sci Adv (2022) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:250; loading ...
BD Biosciences CD24 antibody (BD Biosciences, 561644) was used in flow cytometry on human samples at 1:250. Nat Commun (2021) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 3a, s5a
BD Biosciences CD24 antibody (BD Biosciences, 555427) was used in flow cytometry on human samples (fig 3a, s5a). Oncogenesis (2021) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:50; loading ...; fig 1e
BD Biosciences CD24 antibody (BD Bioscience, 561646) was used in flow cytometry on human samples at 1:50 (fig 1e). elife (2020) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (ML5)
  • mass cytometry; human; 500 ug/ml; loading ...; fig s11a
BD Biosciences CD24 antibody (BD, ML5) was used in mass cytometry on human samples at 500 ug/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig 3c). Breast Cancer Res (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig s10b
BD Biosciences CD24 antibody (BD Biosciences, 562405) was used in flow cytometry on human samples (fig s10b). Nat Commun (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; mouse; loading ...; fig s3g
BD Biosciences CD24 antibody (BD, 555427) was used in flow cytometry on mouse samples (fig s3g). Cell (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 2s
BD Biosciences CD24 antibody (BD Pharmingen, 555426) was used in flow cytometry on human samples (fig 2s). Br J Cancer (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:100; loading ...; fig 1c
BD Biosciences CD24 antibody (BD Biosciences, 560991) was used in flow cytometry on human samples at 1:100 (fig 1c). elife (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD24 antibody (BD Biosciences, 555427) was used in flow cytometry on human samples (fig 3e). EBioMedicine (2019) ncbi
mouse monoclonal (ML5)
  • mass cytometry; human; loading ...; fig 3a
BD Biosciences CD24 antibody (BD Biosciences, 555426) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; rat; fig 7a
BD Biosciences CD24 antibody (BD Horizon, ML5) was used in flow cytometry on rat samples (fig 7a). PLoS ONE (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig 1c). J Clin Invest (2019) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:50; loading ...; fig 8e
BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples at 1:50 (fig 8e). Oncotarget (2018) ncbi
mouse monoclonal (ML5)
  • western blot; mouse; 1:100; loading ...; fig s1a
BD Biosciences CD24 antibody (BD Biosciences, 562789) was used in western blot on mouse samples at 1:100 (fig s1a). Nat Commun (2018) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s4c
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig s4c). Cell (2018) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:20; fig 3g
BD Biosciences CD24 antibody (BD Biosciences, 555427) was used in flow cytometry on human samples at 1:20 (fig 3g). Neurosci Lett (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 3e
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples (fig 3e). Mol Cancer (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig 2a). Genome Biol (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 4c
BD Biosciences CD24 antibody (BD Biosciences, 561646) was used in flow cytometry on human samples (fig 4c). Int J Oncol (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1s1
In order to investigate DNA repair in CD44+/CD24- cells, BD Biosciences CD24 antibody (BD Bioscience, 562789) was used in flow cytometry on human samples (fig 1s1). elife (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 4a
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD24 antibody (BD Bioscience, 561644) was used in flow cytometry on human samples (fig 4a). Sci Rep (2017) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 3c
In order to study the effect of PIK3CA in breast cancer., BD Biosciences CD24 antibody (BD Bioscience, 555427) was used in flow cytometry on human samples (fig 3c). PLoS ONE (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:20; loading ...; fig 4j
BD Biosciences CD24 antibody (BD Pharmingen, 555427) was used in flow cytometry on human samples at 1:20 (fig 4j). J Clin Invest (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; tbl 1
BD Biosciences CD24 antibody (Becton-Dickinson, 55426) was used in flow cytometry on human samples (tbl 1). Int J Oncol (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of galectin-3 in gastrointestinal cancer stem cells, BD Biosciences CD24 antibody (BD, 561646) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; mouse; loading ...; fig 7B
In order to propose that lincRNA-RoR and miR10b distinguish aggressive clones from non-aggressive clones of ductal carcinoma in situ-invasive ductal carcinoma, BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on mouse samples (fig 7B). Oncotarget (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 3f
BD Biosciences CD24 antibody (BD Bioscience, 555427) was used in flow cytometry on human samples (fig 3f). Oncotarget (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:40; loading ...; fig s5b
BD Biosciences CD24 antibody (BD Bioscience, 555428) was used in flow cytometry on human samples at 1:40 (fig s5b). Oncotarget (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 4
In order to elucidate regulation of E-cadherin and CD24 by determination of cell fate transition and impeding tumor initiation and progression in breast cancer via HOXA5, BD Biosciences CD24 antibody (BD Pharmigen, ML5) was used in flow cytometry on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD, ML5) was used in flow cytometry on human samples . JCI Insight (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 2
BD Biosciences CD24 antibody (BD Bioscience, 555428) was used in flow cytometry on human samples (fig 2). Toxins (Basel) (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s4
In order to assess the effects of lenalidomide on normal human plasma cell generation, BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples (fig s4). Oncotarget (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:100; loading ...; fig 1b
BD Biosciences CD24 antibody (BD Biosciences, 555427) was used in flow cytometry on human samples at 1:100 (fig 1b). Oncol Lett (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD24 antibody (BD, 555428) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 4
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig 4). Nucleus (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 1b
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig 1b). Science (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:10; fig 1
BD Biosciences CD24 antibody (BD, 560991) was used in flow cytometry on human samples at 1:10 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 4
BD Biosciences CD24 antibody (BD Pharmingen, ML5) was used in flow cytometry on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s1
In order to analyze the DUSP family members and their differential roles in epithelial to mesenchymal transition and cancer stem cell regulation in breast cancer, BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:100; fig s6
BD Biosciences CD24 antibody (BD, ML5) was used in flow cytometry on human samples at 1:100 (fig s6). Nat Commun (2016) ncbi
mouse monoclonal (ML5)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 1
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples (fig 1). Int J Oncol (2016) ncbi
mouse monoclonal (ML5)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 3
In order to characterize the influence on NK cell cytotoxicity by differential expression of ligands for DNAM-1 and NKG2D receptors by epithelial ovarian cancer-derived exosomes, BD Biosciences CD24 antibody (BD Bioscience, ML5) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 3). Tumour Biol (2016) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 1
BD Biosciences CD24 antibody (BD, 555428) was used in flow cytometry on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; tbl 1
BD Biosciences CD24 antibody (BD bioscience, 555427) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:200
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples at 1:200. Nat Commun (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 3G
BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples (fig 3G). Oncotarget (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s1
BD Biosciences CD24 antibody (BD Pharmingen, 555428) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s2
BD Biosciences CD24 antibody (BD Bioscience, 555428) was used in flow cytometry on human samples (fig s2). EMBO Mol Med (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD24 antibody (BD Pharmingen, 561647) was used in flow cytometry on human samples (fig 4a). Oncotarget (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s1
BD Biosciences CD24 antibody (BD Pharmingen, ML5) was used in flow cytometry on human samples (fig s1). Nat Cell Biol (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
In order to generate patient-derived iPSCs from a Li-Fraumeni syndrome family and assess the role of mutant p53 in the development of osteosarcoma, BD Biosciences CD24 antibody (BD Biosciences, 555427) was used in flow cytometry on human samples . Cell (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig s3
In order to study promotion of collective invasion by an epigenetically distinct breast cancer cell subpopulation, BD Biosciences CD24 antibody (BD Biosciences, 561644) was used in flow cytometry on human samples (fig s3). J Clin Invest (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD Biosciences, clone ML5) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 3
BD Biosciences CD24 antibody (BD Pharmingen, ML5) was used in flow cytometry on human samples (fig 3). Blood (2015) ncbi
mouse monoclonal (ML5)
  • immunocytochemistry; human; fig 5c
BD Biosciences CD24 antibody (BD, 555426) was used in immunocytochemistry on human samples (fig 5c). Nat Commun (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD Pharmingen, ML5) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:100; fig 4
BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples at 1:100 (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD, 561647) was used in flow cytometry on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; fig 6
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BD Biosciences CD24 antibody (BD Pharmingen, ML5) was used in flow cytometry on human samples (fig 6). PLoS ONE (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; 1:50; fig 1
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples at 1:50 (fig 1). Nat Cell Biol (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; mouse
BD Biosciences CD24 antibody (BD Pharmingen, 555428) was used in flow cytometry on mouse samples . J Biol Chem (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD bioscience, 561646) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, BD Biosciences CD24 antibody (Becton Dickinson, clone ML5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
In order to identify the metabolic phenotype associated with breast cancer stem cells, BD Biosciences CD24 antibody (BD Pharmingen, 561646) was used in flow cytometry on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
In order to characterize CD81(+) and CD63(+) subpopulations of exosomes released from B-cell lymphoma cell lines, BD Biosciences CD24 antibody (BD Biosciences, 555428) was used in flow cytometry on human samples . Clin Ther (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD, 560992) was used in flow cytometry on human samples . Cell Tissue Res (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BD Biosciences CD24 antibody (BD, ML5) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
  • immunocytochemistry; human
BD Biosciences CD24 antibody (BD Biosciences, 555426) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Cytotechnology (2014) ncbi
mouse monoclonal (ML5)
  • flow cytometry; human
BD Biosciences CD24 antibody (BD Biosciences, ML5) was used in flow cytometry on human samples . J Allergy Clin Immunol (2014) ncbi
mouse monoclonal (ML5)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx, BD Biosciences CD24 antibody (BD, ML5) was used in immunohistochemistry - paraffin section on human samples at 1:100. Laryngoscope (2014) ncbi
mouse monoclonal (ML5)
  • immunohistochemistry - frozen section; human; 1:200
BD Biosciences CD24 antibody (BD Bioscience, 555426) was used in immunohistochemistry - frozen section on human samples at 1:200. PLoS ONE (2013) ncbi
Articles Reviewed
  1. Bath N, Verhoven B, Wilson N, Zeng W, Zhong W, Coons L, et al. APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model. PLoS ONE. 2022;17:e0275564 pubmed publisher
  2. Chen Y, Lu C, Cheng W, Kuo K, Yu C, Ho H, et al. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids. BMC Cancer. 2022;22:967 pubmed publisher
  3. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  4. Iwahashi N, Umakoshi H, Seki T, Gomez Sanchez C, Mukai K, Suematsu M, et al. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution. J Clin Endocrinol Metab. 2022;107:2439-2448 pubmed publisher
  5. Li J, Camirand A, Zakikhani M, Sellin K, Guo Y, Luan X, et al. Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal. JBMR Plus. 2022;6:e10587 pubmed publisher
  6. Chen Y, Xu J, Pan W, Xu X, Ma X, Chu Y, et al. Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cells. Thorac Cancer. 2022;13:1961-1973 pubmed publisher
  7. Haddock S, Alban T, Turcan S, Husic H, Rosiek E, Ma X, et al. Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells. Neoplasia. 2022;28:100790 pubmed publisher
  8. Kumar B, Adebayo A, Prasad M, Capitano M, Wang R, Bhat Nakshatri P, et al. Tumor collection/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity. Sci Adv. 2022;8:eabh3375 pubmed publisher
  9. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed publisher
  10. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  11. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  12. Shams A, Binothman N, Boudreault J, Wang N, Shams F, Hamam D, et al. Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis. Oncogenesis. 2021;10:10 pubmed publisher
  13. Wen Y, Hou Y, Yi X, Sun S, Guo J, He X, et al. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. Theranostics. 2021;11:1795-1813 pubmed publisher
  14. Karnan S, Ota A, Murakami H, Rahman M, Hasan M, Wahiduzzaman M, et al. Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma. Cell Death Discov. 2020;6:127 pubmed publisher
  15. Oliemuller E, Newman R, Tsang S, Foo S, Muirhead G, Noor F, et al. SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. elife. 2020;9: pubmed publisher
  16. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  17. Pseftogas A, Xanthopoulos K, Poutahidis T, Ainali C, Dafou D, Panteris E, et al. The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling. Cancers (Basel). 2020;12: pubmed publisher
  18. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  19. Bredenkamp N, Yang J, Clarke J, Stirparo G, von Meyenn F, Dietmann S, et al. Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency. Stem Cell Reports. 2019;13:1083-1098 pubmed publisher
  20. Valentiner U, Knips J, Pries R, Clauditz T, Münscher A, Sauter G, et al. Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019;11: pubmed publisher
  21. Fusco P, Parisatto B, Rampazzo E, Persano L, Frasson C, Di Meglio A, et al. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours. BMC Cancer. 2019;19:970 pubmed publisher
  22. Ren J, Smid M, Iaria J, Salvatori D, van Dam H, Zhu H, et al. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res. 2019;21:109 pubmed publisher
  23. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  24. Greenberg R, Long H, Swigut T, Wysocka J. Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome. Cell. 2019;178:1421-1436.e24 pubmed publisher
  25. Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8: pubmed publisher
  26. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  27. Neftel C, Laffy J, Filbin M, Hara T, Shore M, Rahme G, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019;178:835-849.e21 pubmed publisher
  28. Wang H, Xiang D, Liu B, He A, Randle H, Zhang K, et al. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer. Cell. 2019;178:135-151.e19 pubmed publisher
  29. Capulli M, Hristova D, Valbret Z, Carys K, Arjan R, Maurizi A, et al. Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry. Br J Cancer. 2019;121:157-171 pubmed publisher
  30. Essex A, Pineda J, Acharya G, Xin H, Evans J, Iorns E, et al. Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. elife. 2019;8: pubmed publisher
  31. Moamer A, Hachim I, Binothman N, Wang N, Lebrun J, Ali S. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis. EBioMedicine. 2019;: pubmed publisher
  32. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  33. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  34. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed publisher
  35. Zaborowski M, Lee K, Na Y, Sammarco A, Zhang X, Iwanicki M, et al. Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles. Cell Rep. 2019;27:255-268.e6 pubmed publisher
  36. Bath N, Ding X, Wilson N, Verhoven B, Boldt B, Sukhwal A, et al. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model. PLoS ONE. 2019;14:e0211865 pubmed publisher
  37. Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J Clin Invest. 2019;129:1047-1060 pubmed publisher
  38. Kinchen J, Chen H, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner Corbett D, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018;175:372-386.e17 pubmed publisher
  39. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed publisher
  40. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  41. Nguyen X, Dauvilliers Y, Quériault C, Pérals C, Romieu Mourez R, Paulet P, et al. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun. 2018;94:134-142 pubmed publisher
  42. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  43. Espinoza Sánchez N, Enciso J, Pelayo R, Fuentes Panana E. An NF?B-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features. Oncotarget. 2018;9:26679-26700 pubmed publisher
  44. Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed publisher
  45. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
  46. Azizi H, Hwang J, Suen V, Kang N, Somvanshi R, Tadavarty R, et al. Sleep deprivation induces changes in 5-HT actions and 5-HT1A receptor expression in the rat hippocampus. Neurosci Lett. 2017;655:151-155 pubmed publisher
  47. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed publisher
  48. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  49. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  50. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  51. Litzenburger U, Buenrostro J, Wu B, Shen Y, Sheffield N, Kathiria A, et al. Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol. 2017;18:15 pubmed publisher
  52. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  53. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  54. Lango Chavarría M, Chimal Ramírez G, Ruiz Tachiquín M, Espinoza Sánchez N, Suárez Arriaga M, Fuentes Pananá E. A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients. Int J Oncol. 2017;50:432-440 pubmed publisher
  55. Pal D, Pertot A, Shirole N, Yao Z, Anaparthy N, Garvin T, et al. TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells. elife. 2017;6: pubmed publisher
  56. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  57. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  58. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  59. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  60. Kumazoe M, Takai M, Bae J, Hiroi S, Huang Y, Takamatsu K, et al. FOXO3 is essential for CD44 expression in pancreatic cancer cells. Oncogene. 2017;36:2643-2654 pubmed publisher
  61. Dallavalle C, Albino D, Civenni G, Merulla J, Ostano P, Mello Grand M, et al. MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression. J Clin Invest. 2016;126:4585-4602 pubmed publisher
  62. Singh S, Zeng X, Zhao J, Liu Y, Hou G, Liu H, et al. The lipolysis pathway sustains normal and transformed stem cells in adult Drosophila. Nature. 2016;538:109-113 pubmed publisher
  63. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  64. Puvanenthiran S, Essapen S, Seddon A, Modjtahedi H. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs. Int J Oncol. 2016;49:1825-1838 pubmed publisher
  65. Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, SCHROEDER J. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. 2016;7:60776-60792 pubmed publisher
  66. Ilmer M, Mazurek N, Byrd J, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7:e2337 pubmed publisher
  67. Wang H, Ning Z, Li Y, Zhu X, Meng Z. Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Mol Med Rep. 2016;14:1907-14 pubmed publisher
  68. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  69. Duru N, Gernapudi R, Lo P, Yao Y, Wolfson B, Zhang Y, et al. Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells. Oncotarget. 2016;7:47511-47525 pubmed publisher
  70. Nami B, Donmez H, Kocak N. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells. Exp Toxicol Pathol. 2016;68:419-26 pubmed publisher
  71. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  72. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  73. Kwak J, Lee N, Lee H, Hong I, Nam J. HIF2?/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy. Oncotarget. 2016;7:43518-43533 pubmed publisher
  74. Clark A, Petty H. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy. Sci Rep. 2016;6:27039 pubmed publisher
  75. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  76. Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R, et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35:5539-5551 pubmed publisher
  77. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  78. Lu K, Wang B, Chi W, Chang Chien J, Yang J, Lee H, et al. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27. Toxins (Basel). 2016;8: pubmed publisher
  79. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  80. Leung C, Mak W, Kai A, Chan K, Lee T, Ng I, et al. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/?-catenin signaling. Oncotarget. 2016;7:29371-86 pubmed publisher
  81. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  82. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  83. Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed publisher
  84. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  85. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  86. Hardy K, Wu F, Tu W, Zafar A, Boulding T, McCuaig R, et al. Identification of chromatin accessibility domains in human breast cancer stem cells. Nucleus. 2016;7:50-67 pubmed publisher
  87. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  88. Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed publisher
  89. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  90. Boulding T, Wu F, McCuaig R, Dunn J, Sutton C, Hardy K, et al. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer. PLoS ONE. 2016;11:e0148065 pubmed publisher
  91. Wang X, Jung Y, Jun S, Lee S, Wang W, Schneider A, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun. 2016;7:10633 pubmed publisher
  92. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  93. Cheung S, Chuang P, Huang H, Hwang Verslues W, Cho C, Yang W, et al. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A. 2016;113:960-5 pubmed publisher
  94. Todoroki K, Ogasawara S, Akiba J, Nakayama M, Naito Y, Seki N, et al. CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. Int J Oncol. 2016;48:99-109 pubmed publisher
  95. Stempin S, Engel A, Winkler N, Buhrke T, Lampen A. Morphological and molecular characterization of the human breast epithelial cell line M13SV1 and its tumorigenic derivatives M13SV1-R2-2 and M13SV1-R2-N1. Cancer Cell Int. 2015;15:110 pubmed publisher
  96. Labani Motlagh A, Israelsson P, Ottander U, Lundin E, Nagaev I, Nagaeva O, et al. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. Tumour Biol. 2016;37:5455-66 pubmed publisher
  97. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  98. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed publisher
  99. Iriondo O, Rábano M, Domenici G, Carlevaris O, López Ruiz J, Zabalza I, et al. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions. Oncotarget. 2015;6:31721-39 pubmed publisher
  100. Nie S, McDermott S, Deol Y, Tan Z, Wicha M, Lubman D. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations. Proteomics. 2015;15:3772-83 pubmed publisher
  101. Monteiro Carvalho Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N, et al. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS ONE. 2015;10:e0136145 pubmed publisher
  102. Cho M, Park J, Choi H, Park M, Won H, Park Y, et al. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat Commun. 2015;6:7821 pubmed publisher
  103. Wei X, Dou X, Bai J, Luo X, Qiu S, Xi D, et al. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget. 2015;6:21704-17 pubmed
  104. Cioffi M, D Alterio C, Camerlingo R, Tirino V, Consales C, Riccio A, et al. Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. Sci Rep. 2015;5:10357 pubmed publisher
  105. Meidhof S, Brabletz S, Lehmann W, Preca B, Mock K, Ruh M, et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med. 2015;7:831-47 pubmed publisher
  106. Jung K, Gupta N, Wang P, Lewis J, Gopal K, Wu F, et al. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter. Oncotarget. 2015;6:10366-73 pubmed
  107. Ross J, Huh D, Noble L, Tavazoie S. Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol. 2015;17:651-64 pubmed publisher
  108. Lee D, Su J, Kim H, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240-54 pubmed publisher
  109. Westcott J, Prechtl A, Maine E, Dang T, Esparza M, Sun H, et al. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. J Clin Invest. 2015;125:1927-43 pubmed publisher
  110. Sutherland D, Illingworth A, Keeney M, Richards S. High-Sensitivity Detection of PNH Red Blood Cells, Red Cell Precursors, and White Blood Cells. Curr Protoc Cytom. 2015;72:6.37.1-30 pubmed publisher
  111. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  112. Liew M, Farley M, Andreasen J, Parker C, Wittwer C. Rare event counting of CD59- red cells in human blood: A 47-month experience using PNH consensus guidelines for WBC and RBC testing in a reference lab. Cytometry B Clin Cytom. 2015;88:261-9 pubmed publisher
  113. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed publisher
  114. Wang L, Liu R, Ye P, Wong C, Chen G, Zhou P, et al. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun. 2015;6:5909 pubmed publisher
  115. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  116. Ventelä S, Sittig E, Mannermaa L, Mäkelä J, Kulmala J, Löyttyniemi E, et al. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget. 2015;6:144-58 pubmed
  117. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  118. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed publisher
  119. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  120. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  121. Chandrasekaran S, Marshall J, Messing J, Hsu J, King M. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS ONE. 2014;9:e111487 pubmed publisher
  122. Soncini D, Caffa I, Zoppoli G, Cea M, Cagnetta A, Passalacqua M, et al. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. J Biol Chem. 2014;289:34189-204 pubmed publisher
  123. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  124. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  125. Zhang Y, Xia J, Li Q, Yao Y, Eades G, Gernapudi R, et al. NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity. J Biol Chem. 2014;289:31310-8 pubmed publisher
  126. So J, Lin J, Wahler J, Liby K, Sporn M, Suh N. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer. PLoS ONE. 2014;9:e107616 pubmed publisher
  127. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  128. Ciavardelli D, Rossi C, Barcaroli D, Volpe S, Consalvo A, Zucchelli M, et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death Dis. 2014;5:e1336 pubmed publisher
  129. Oksvold M, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, et al. Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells. Clin Ther. 2014;36:847-862.e1 pubmed publisher
  130. Pei M, Li J, Zhang Y, Liu G, Wei L, Zhang Y. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356:391-403 pubmed publisher
  131. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  132. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  133. Cyr A, Kulak M, Park J, Bogachek M, Spanheimer P, Woodfield G, et al. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis. Oncogene. 2015;34:436-44 pubmed publisher
  134. Tang X, Richardson W, Fitch R, Brown C, Isaacs R, Chen J. A new non-enzymatic method for isolating human intervertebral disc cells preserves the phenotype of nucleus pulposus cells. Cytotechnology. 2014;66:979-86 pubmed publisher
  135. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed publisher
  136. Bradford C, Kumar B, Bellile E, Lee J, Taylor J, D SILVA N, et al. Biomarkers in advanced larynx cancer. Laryngoscope. 2014;124:179-87 pubmed publisher
  137. Ghebeh H, Sleiman G, Manogaran P, Al Mazrou A, Barhoush E, Al Mohanna F, et al. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer. 2013;13:289 pubmed publisher
  138. Zakharchenko O, Cojoc M, Dubrovska A, Souchelnytskyi S. A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance. PLoS ONE. 2013;8:e65163 pubmed publisher
  139. Krishan A, Ganjei Azar P, Hamelik R, Sharma D, Reis I, Nadji M. Flow immunocytochemistry of marker expression in cells from body cavity fluids. Cytometry A. 2010;77:132-43 pubmed publisher
  140. Metsuyanim S, Harari Steinberg O, Buzhor E, Omer D, Pode Shakked N, Ben Hur H, et al. Expression of stem cell markers in the human fetal kidney. PLoS ONE. 2009;4:e6709 pubmed publisher
  141. Wei C, Anolik J, Cappione A, Zheng B, Pugh Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007;178:6624-33 pubmed
  142. Fromm J, Kussick S, Wood B. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting. Am J Clin Pathol. 2006;126:764-80 pubmed